CME Webcast Updates Physicians on Scleroderma

OSUWexnerbloglogo2014 CME Webcast Updates Physicians on Scleroderma. In many ways, scleroderma is still a mystery but today, we do have treatments that can relieve symptoms and improve outcomes. On this CME webcast, we are going to be taking a close look at scleroderma. Let me welcome today’s guests. Dr. Ali Ajam is a rheumatologist and Assistant Professor of Internal Medicine who oversees the Ohio State University Scleroderma Clinic. And Dr. Steven Dean is Professor of Internal Medicine and specialist in vascular medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY classic clinical manifestations of scleroderma associated Raynaud phenomenon; and LIST medications typically used to treat scleroderma associated Raynaud phenomenon; DIAGNOSING scleroderma, and being able to order and decipher pertinent labs; and DEVELOP screening guidelines for pulmonary involvement.

You’ll also learn about the following:

  • Common presenting signs and symptoms
  • Raynaud phenomenon
  • Scleroderma mimics
  • Scleroderma and pregnancy
  • Exercise and scleroderma
  • Raynaud phenomenon and the feet

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

To Ablate Or Not To Ablate: Current Management of Atrial Fibrillation

OSUWexnerbloglogo2014 CME Webcast Discusses To Ablate Or Not To Ablate Current Management of Atrial Fibrillation. In 1998, Dr. Michel Hice-uh-gaire, a cardiologist in Bordeaux, France, determined that the electrical triggers for atrial fibrillation were most commonly located in the pulmonary veins and that he could cure atrial fibrillation by ablating these triggers with a catheter. In the 2 decades since, ablation has a key element in the cardiologist’s toolbox to treat atrial fibrillation. But which patients are best served by medical treatment and which ones are best treated with catheter ablation? On this CME webcast, we’re going to explore this question. Joining our moderator is cardiac electrophysiologist and Professor of Internal Medicine at the Ohio State University, Dr. John Hummel.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the risks of atrial fibrillation; and Understand when to initiate a strategy to maintain sinus rhythm.

You’ll also learn about the following:

  • Clinical implications of atrial fibrillation
  • Patient selection for atrial ablation
  • The ablation procedure
  • Return to work and exercise
  • Medication management after atrial ablation
  • Maze procedure
  • Management of recurrent atrial fibrillation after an ablation procedure
  • Apple Watch EKG app

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Explore Obesity and Rheumatologic-Musculoskeletal Disease

OSUWexnerbloglogo2014 Explore Obesity and Rheumatologic/Musculoskeletal Disease. With moderate obesity comes more diabetes, more sleep apnea, more heart disease and today you’re going to learn, more arthritis. Joining our moderator, Dr. Jim Allen, in the studio to tell us about the two-way relationship between obesity and rheumatologic disease is Assistant Professor of Internal Medicine from the Division of Rheumatology, Dr. Matthew Husa.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the importance of obesity as it relates to rheumatologic and/or musculoskeletal disease; and DISCUSS treatment options and changes in therapy for obese patients with musculoskeletal and/or rheumatologic disease.

You’ll also learn about the following:

  • Whether weight loss improves arthritis symptoms
  • Obesity and back pain
  • Prognosis for radiographic improvement with weight loss
  • Obesity and gout
  • Exercise selection for obese patients with arthritis
  • Steroids and other rheumatologic medications and weight loss

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education for Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education for Multiple Sclerosis. In the 1950’s and 1960’s, almost everyone in America knew Annette Funicello and when she died, it was like a member of everyone’s family died. Hearing about her illness makes us all too cognizant of just how bad MS can be. There has been an enormous change in the way that we treat multiple sclerosis since Annette Funicello was first diagnosed with it 25 years ago and on this CME webcast, we’re going to hear about the breakthroughs that are offering hope to people who a generation ago would not have had the luxury of hope. Joining our moderator, Dr. Jim Allen, in the studio are two of Ohio State University’s experts in MS. First, we have Dr. Jacqueline Nicholas who is an Assistant Professor of Neurology and second we have Dr. Aaron Boster who is also an Assistant Professor of Neurology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the neurological symptoms that should raise clinical suspicion of a diagnosis of multiple sclerosis; INITIATE prompt referral to a neurologist in patients presenting with symptoms that may be indicative of a diagnosis of multiple sclerosis; ESTABLISH a communication strategy with the treating neurologist to discuss treatment, side effects, and barriers to adherence in patients with multiple sclerosis.

You’ll also learn about the following:

  • Challenges in diagnosis of multiple sclerosis
  • Changes in treatment options for patients with multiple sclerosis
  • Management of depression in patients with multiple sclerosis
  • Deep brain stimulation in multiple sclerosis
  • Heredity and multiple sclerosis
  • Management of multiple sclerosis in children
  • Natural history of multiple sclerosis
  • Exercise and multiple sclerosis
  • Diet and multiple sclerosis
  • Sexual dysfunction in multiple sclerosis
  • Urinary dysfunction in multiple sclerosis
  • Spasticity
  • Role of corticosteroids in managing multiple sclerosis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.